Trends Shaping Asia Pacific NGS Automation Market
Meticulous Research®, a leading global market research company, published a research report titled, 'Asia-Pacific NGS Automation Market by Product (Platform, Consumables), Sequencing Type (Whole Genome, Exome, Targeted), Application (Drug Discovery, Diagnostics), End User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Academic) - Forecast to 2032.'
According to this latest publication
from Meticulous Research®, the Asia-Pacific NGS automation market is
expected to reach $371
million by 2032, at a CAGR of 16.3% from 2025 to 2032.The growth of the
Asia-Pacific NGS automation market is driven by the growing demand for NGS
technology in clinical & research applications, the rising incidence of
cancer, and increasing pharmaceutical R&D investments and healthcare
expenditures. However, the high costs of automation workstations restrain the
market's growth.
The increasing application of NGS in
genetic disease testing and government initiatives aimed at boosting the
adoption of advanced technologies are expected to create market growth
opportunities. However, regulatory & standardization concerns related to
diagnostic testing and the need to train personnel on the use of NGS automation
software are major challenges for market growth.
Key Players
The key players operating in the
Asia-Pacific NGS automation market are Agilent Technologies, Inc. (U.S.),
Danaher Corporation (U.S.), Eppendorf AG (Germany), Hamilton Company (U.S.),
PerkinElmer, Inc. (U.S.), Tecan Group Ltd. (Switzerland), PrimaDiag SAS
(France), BRAND GMBH + CO KG (Germany), Hudson Robotics (U.S.), SPT Labtech
(U.K.), Thermo Fisher Scientific, Inc. (U.S.), and F. Hoffmann-La Roche Ltd.
(Switzerland).
Asia-Pacific NGS Automation Market: Future Outlook
The Asia-Pacific NGS automation market
is segmented by Product (Workstations/Robotic Platforms and Reagents &
Consumables), Sequencing Type (Whole Genome Sequencing (WGS), Whole Exome
Sequencing, Targeted Genome Sequencing, and Other Sequencing Types),
Application (Drug Discovery, Clinical Diagnostics [Reproductive Health
Diagnostics, Oncology Diagnostics, Infectious Diseases Diagnostics, and Other
Clinical Diagnostics], and Other Applications), End User (Hospitals &
Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic
& Research Institutes, and Other End Users), and Geography. The study also
evaluates industry competitors and the market at the country level.
Among all products studied in this
report, the
workstations/robotic platforms segment is expected to register the highest CAGR
during the forecast period. The growth of this segment is attributed to the
increasing use of robotic platforms for liquid handling or pipetting to
increase process efficiency, reduce manual errors, and reduce the time
required. Additionally, increasing pharmaceutical R&D expenditure and
rising applications of NGS in various fields are driving the market's growth.
Among all sequencing types studied
in this report, in 2025,
the whole genome sequencing segment is expected to account for the largest
share of the Asia-Pacific NGS automation market. The large market share of this
segment can be attributed to the increasing demand for whole genome sequencing
for various applications, including the analysis of tumors, studying the causes
and progression of diseases, selecting plants and animals for agricultural
breeding programs, and examining common genetic variations among populations.
Furthermore, whole genome sequencing facilitates the identification of known
virulence factors and the derivation of comprehensive resistance profiles of
pathogens against antibiotic drugs, further driving its adoption.
Among all applications studied in
this report, the clinical
diagnostics segment is expected to register the highest CAGR during the
forecast period. The growth of this segment can be attributed to the growing
utilization of NGS automation products in hospitals and diagnostic laboratories
for preimplantation genetic testing, NIPT testing, carrier testing, and other
applications. Additionally, factors such as the rising incidence of genetic
disorders in infants, increasing awareness regarding genetic testing, and the
introduction of advanced non-invasive prenatal testing (NIPT) products
contribute to the growth of this segment. According to the Chinese Center for
Disease Control and Prevention, the prevalence rate of congenital heart disease
was 80.77 per 10,000 births between 2013 and 2022.
Among all end users studied in this
report, in 2025, the
pharmaceutical & biotechnology companies segment is expected to account for
the largest share of the Asia-Pacific NGS automation market. The large market
share of this segment can be attributed to the significant R&D investments
made by pharmaceutical and biotechnology companies, coupled with the increasing
incidence of chronic diseases, which drive the need for improved diagnostics
and therapeutic approaches, thereby increasing the adoption of NGS technologies
among pharmaceutical and biotechnology companies.
Geographic Review
This research report provides a
comprehensive analysis of the market across major countries in the Asia-Pacific
region, including Japan, China, India, South Korea, Australia, Thailand,
Singapore, Indonesia, and the Rest of Asia-Pacific. China is expected to
register the highest CAGR during the forecast period. This growth is driven by
several factors, including the increasing government focus on sequencing
projects, the establishment of new healthcare facilities, the large population
of patients with gene-associated disorders, and the increasing research
activities aimed at developing personalized medicines. Additionally, the
increasing collaborations among government agencies and key players to expand
genetic testing further support the market's growth in the country. For
instance, the Newborn Foundation (U.S.), the Chinese Ministry of Health, and
the National Office of Maternal and Child Health Services have collaborated for
over a decade to conduct newborn screening for congenital heart defects and neonatal
hypoxemia.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5790
Key questions answered in the
report:
·
Which are
the high-growth market segments in terms of the product, sequencing type,
application, end user, and country?
·
What was
the historical market for NGS automation products in Asia-Pacific?
·
What are
the market forecasts and estimates for the period 2025–2032?
·
What are
the major drivers, restraints, challenges, and opportunities in the
Asia-Pacific NGS automation market?
·
Who are
the major players in the Asia-Pacific NGS automation market?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment